Verification of the effectiveness of a community pharmacist intervention program for safe continuation of medication in patients newly taking DPP-4 inhibitors

Verification of the effectiveness of a pharmacy pharmacist intervention program for safe continuation of drug use in patients newly taking DPP-4 inhibitors - Verification of the effectiveness of a pharmacy pharmacist intervention program for safe continuation of drug use in patients newly taking DPP-4 inhibitors

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000053494

Enrollment

300

Registered

2024-02-02

Start date

2024-02-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus

Interventions

Medication follow-up and medication guidance using the developed follow-up sheet will be conducted in accordance with the period when side effects of gastrointestinal symptoms are most likely to occur

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who started taking new DPP-4 inhibitors.

Exclusion criteria

Exclusion criteria: Patients taking antipsychotics, antidepressants, or corticosteroids.

Design outcomes

Primary

Measure	Time frame
Percentage of patients who suspected gastrointestinal symptoms caused by DPP4 inhibitors and reported them to their doctor through medicotion inquiry or tracing Report	—

Countries

Japan

Contacts

Public ContactAyana Funabashi

Osaka Medical and Pharmaceutical University graduate student

ainj08082826882@docomo.ne.jp080-8282-6882

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026